title: Clinical use of Haemate-P in inherited von Willebrand's disease: a patient with type 3 VWD and recurrent menometrorrhagia.
authors.forename: R
authors.initials: R
authors.lastname: Dolatkhah
authors.forename: I A
authors.initials: IA
authors.lastname: Kermani
authors.forename: Z
authors.initials: Z
authors.lastname: Sanaat
authors.forename: S
authors.initials: S
authors.lastname: Seifi
authors.forename: J E
authors.initials: JE
authors.lastname: Ziaei
authors.forename: A
authors.initials: A
authors.lastname: Nikanfar
authors.forename: A
authors.initials: A
authors.lastname: Esfehani
authors.forename: S H
authors.initials: SH
authors.lastname: Chavoushi
mesh_terms: D000328:Adult; D004338:Drug Combinations; D005169:Factor VIII / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000032:analysis / Q000187:drug effects; D006801:Humans; D008595:Menorrhagia / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult; D056729:von Willebrand Disease, Type 3 / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; D006454:Hemoglobins; C509423:factor VIII, von Willebrand factor drug combination; D014841:von Willebrand Factor; D005169:Factor VIII